PATH | VRL
Menu

Influenza Vaccine Effectiveness in the United States During the 2015–2016 Season

This article, published in The New England Journal of Medicine, reports the results of a study to examine the effectiveness of the live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) formulations used in the 2015–2016 flu season. Among children 2 to 17 years old, the IIV formulation was shown be 60 percent effective, while the LAIV was not observed to be effective. The LAIV's lack of efficacy led the Advisory Committee on Immunization Practices to make an interim recommendation not to use the LAIV formulation during the 2016–2017 influenza season. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author: Jackson ML, Chung JR, Jackson LA, et al.

Published: 2017

» Visit web page (English)

(Located at www.nejm.org)

Citation: Jackson ML, Chung JR, Jackson LA, et al. Influenza Vaccine Effectiveness in the United States During the 2015–2016 Season. The New England Journal of Medicine. 2017;377(6):534-543. 

Resource types: Peer-reviewed journal

Diseases/vaccines: Influenza

Topics: Vaccine safety and performance, Disease/vaccine specific information, Vaccine stabilization and formulation

Regions: North America and Europe